Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...
3don MSN
Patanjali states Aurogrit may help slow lung cancer cell growth based on its laboratory findings
According to the claim, the Ayurvedic formulation is made from traditional ingredients mentioned in classical texts. Patanjali states that it works at the molecular level in research settings.
Amini: The systemic landscape is constantly changing and is very exciting. It will only become more complicated for our ...
Doraemon's director Shibayama Tsutomu died at the age of 84. He was suffering from lung cancer. To know what the causes of the disease are and what are some of the prevention tips, read on.
TheHealthSite on MSN
Doraemon director Tsutomu Shibayama dies at 84 after battling aggressive lung cancer: Signs of this silent killer
Doraemon director Tsutomu Shibayama Death Cause: Japanese animation figure Shibayama Tsutomu, known for his work on Doraemon, ...
Amini: This varies quite a bit by stage — operable vs. nonoperable — and patients’ performance status and preference. Additionally, more relevant to medical oncology but equally, if not more, ...
Dr Mark Kris highlights a recent study on osimertinib in NSCLC and outlines the best approaches for treatment beyond ...
Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...
In the U.S., FDA approval establishes Opdivo in combination with doxorubicin, vinblastine and dacarbazine (AVD) as the first immunotherapy combination approved for adult and pediatric patients 12 ...
Melanie knew it was serious as her mum had died of lung cancer ...
Trilaciclib protects bone marrow before SCLC chemotherapy, sharply reducing neutropenia, anemia, and thrombocytopenia, improving fatigue and keeping treatment on schedule without weakening tumor kill.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results